Notícias e Atividades da Fennec Pharma

Fennec Pharma é uma empresa listada sob o símbolo FENC (US).

Veja o organograma con seus 17 executivos principais

Biografias mais buscadas da Fennec Pharma

• Jeffrey Hackman, Chief Executive Officer and Director
• Jodi Cook, Director
• Khalid Islam, Chairman of the Board

Recentes movimentos de executivos em Fennec Pharma

• Rostislav Raykov, Director, se aposentou  (Notícia publicada em 29 de abril de 2026).

Criar um alerta
para seguir os movimentos de executivos da Fennec Pharma.

Fennec Pharma possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Fennec Pharma

• Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 | Fennec Pharmaceuticals Inc.
• Press Releases | Fennec Pharmaceuticals Inc.
• Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation | Fennec Pharmaceuticals Inc.
• View more press releases Close

Redes sociais sobre Fennec Pharma

• Fennec Pharma na Wikipedia, Google News e Yahoo Finance
• Fennec Pharma na LinkedIn, X (Twitter) e YouTube